17-80099790-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000574799.5(CCDC40):​n.2981T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,610,396 control chromosomes in the GnomAD database, including 73,542 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 10337 hom., cov: 32)
Exomes 𝑓: 0.29 ( 63205 hom. )

Consequence

CCDC40
ENST00000574799.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.649

Publications

13 publications found
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
CCDC40 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 15
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autoimmune disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-80099790-T-C is Benign according to our data. Variant chr17-80099790-T-C is described in ClinVar as Benign. ClinVar VariationId is 162853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000574799.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
NM_017950.4
MANE Select
c.*15T>C
3_prime_UTR
Exon 20 of 20NP_060420.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCDC40
ENST00000574799.5
TSL:1
n.2981T>C
non_coding_transcript_exon
Exon 16 of 16
CCDC40
ENST00000397545.9
TSL:5 MANE Select
c.*15T>C
3_prime_UTR
Exon 20 of 20ENSP00000380679.4

Frequencies

GnomAD3 genomes
AF:
0.352
AC:
53366
AN:
151808
Hom.:
10320
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.337
Gnomad AMR
AF:
0.216
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.333
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.287
Gnomad OTH
AF:
0.328
GnomAD2 exomes
AF:
0.302
AC:
73977
AN:
245030
AF XY:
0.305
show subpopulations
Gnomad AFR exome
AF:
0.521
Gnomad AMR exome
AF:
0.159
Gnomad ASJ exome
AF:
0.266
Gnomad EAS exome
AF:
0.409
Gnomad FIN exome
AF:
0.329
Gnomad NFE exome
AF:
0.289
Gnomad OTH exome
AF:
0.309
GnomAD4 exome
AF:
0.288
AC:
420697
AN:
1458470
Hom.:
63205
Cov.:
35
AF XY:
0.290
AC XY:
210262
AN XY:
725646
show subpopulations
African (AFR)
AF:
0.525
AC:
17556
AN:
33416
American (AMR)
AF:
0.171
AC:
7624
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
6984
AN:
26094
East Asian (EAS)
AF:
0.453
AC:
17967
AN:
39664
South Asian (SAS)
AF:
0.325
AC:
28004
AN:
86184
European-Finnish (FIN)
AF:
0.340
AC:
17527
AN:
51604
Middle Eastern (MID)
AF:
0.302
AC:
1743
AN:
5764
European-Non Finnish (NFE)
AF:
0.274
AC:
304774
AN:
1110800
Other (OTH)
AF:
0.307
AC:
18518
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
14389
28778
43168
57557
71946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10210
20420
30630
40840
51050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.352
AC:
53424
AN:
151926
Hom.:
10337
Cov.:
32
AF XY:
0.350
AC XY:
26005
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.516
AC:
21370
AN:
41384
American (AMR)
AF:
0.216
AC:
3294
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
889
AN:
3462
East Asian (EAS)
AF:
0.424
AC:
2185
AN:
5150
South Asian (SAS)
AF:
0.327
AC:
1579
AN:
4824
European-Finnish (FIN)
AF:
0.333
AC:
3526
AN:
10574
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.287
AC:
19467
AN:
67940
Other (OTH)
AF:
0.332
AC:
699
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1688
3377
5065
6754
8442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
3763
Bravo
AF:
0.350
Asia WGS
AF:
0.387
AC:
1350
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 07, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

*15T>C in exon 20 of CCDC40: This variant is not expected to have clinical signi ficance because it has been identified in 49.7% (1929/3880) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs2304853).

Primary ciliary dyskinesia 15 Benign:3
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Primary ciliary dyskinesia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glycogen storage disease, type II Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.64
DANN
Benign
0.41
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304853; hg19: chr17-78073589; COSMIC: COSV56408051; COSMIC: COSV56408051; API